Sijmen de Vries, MD MBA
Executive Director and Chief Executive Officer
Nationality: Dutch
Date of initial appointment: October 13, 2008
Mr. Sijmen de Vries was our Chief Executive Officer (CEO) and Executive Officer from 2008 until his resignation at the EGM held on March 4, 2025, following the appointment of Fabrice Chouraqui as our new CEO.
To ensure a smooth hand-over of tasks and responsibilities, Mr. de Vries will remain a strategic advisor to the new CEO until December 31, 2025.
Prior to joining Pharming, Dr. de Vries was the CEO of 4-Antibody and Morphochem AG. He also held senior business and commercial positions at Novartis, Novartis Ophthalmics and at SmithKline Beecham Pharmaceuticals plc.
Dr. de Vries holds an MD degree from the University of Amsterdam and an MBA in General Management from Ashridge Business School (UK). Dr. de Vries is also a Member of the Supervisory Board of BioConnection Investments B.V. and Non-Executive Director of Biodexa Pharmaceuticals plc., formerly Midatech Pharma plc.
ABOUT US | EXECUTIVE COMMITTEE | BOARD OF DIRECTORS | CORPORATE GOVERNANCE